HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polyamine-stimulation of arsenic-transformed keratinocytes.

Abstract
Tumor promotion is strongly associated with inflammation and increased polyamine levels. Our understanding of relevant mechanisms responsible for arsenic-induced cancer remains limited. Previous studies suggest that arsenic targets and dysregulates stem cell populations that remain dormant in the skin until promoted to be recruited out of the bulge stem cell region, thus giving rise to skin tumors. In this study, we explored a possible mechanism by which increased keratinocyte polyamine biosynthesis promotes tumorsphere formation and invasiveness of arsenic-transformed HaCaT keratinocytes (As-HaCaT). Unlike parental HaCaT cells, As-HaCaT cells were tumorigenic in athymic nude mice, and the CD45negative epithelial tumor cells had enriched expression of Toll-Like Receptor 4 (TLR4), CD34 and CXCR4 as did As-HaCaT tumorsphere cultures compared to As-HaCaT monolayer cultures. Ornithine decarboxylase (ODC) overexpressing keratinocytes (Ker/ODC) release increased levels of the alarmin high mobility group box 1 (HMGB1). Ker/ODC conditioned medium (CM) stimulated As-HaCaT but not parental HaCaT tumorsphere formation, and this was inhibited by glycyrrhizin, an inhibitor of HMGB1, and by TAK242, an inhibitor of the HMGB1 receptor TLR4. Compared to parental HaCaT cells, As-HaCaT cells demonstrated greater invasiveness across a Matrigel-coated filter using either fibroblast CM or SDF-1α as chemoattractants. Addition of Ker/ODC CM or HMGB1 dramatically increased As-HaCaT invasiveness. Glycyrrhizin and TAK242 inhibited this Ker/ODC CM-stimulated invasion of As-HaCaT cells but not HaCaT cells. These results show that polyamine-dependent release of HMGB1 promotes the expansion of stem cell-like subpopulations in arsenic-transformed keratinocytes while also increasing their invasiveness, suggesting that polyamines may be a potential therapeutic target for the prevention and treatment of arsenic-initiated skin cancers.
AuthorsEric T Alexander, Kelsey Mariner, Yelizaveta Borodyanskaya, Allyson Minton, Susan K Gilmour
JournalCarcinogenesis (Carcinogenesis) Vol. 40 Issue 8 Pg. 1042-1051 (08 22 2019) ISSN: 1460-2180 [Electronic] England
PMID31190067 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].
Chemical References
  • HMGB1 Protein
  • HMGB1 protein, mouse
  • Polyamines
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • Glycyrrhizic Acid
  • Arsenic
Topics
  • Animals
  • Arsenic (toxicity)
  • Carcinogenesis (drug effects, genetics)
  • Cell Proliferation (drug effects)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Glycyrrhizic Acid (pharmacology)
  • HMGB1 Protein (genetics)
  • Humans
  • Keratinocytes (drug effects, pathology)
  • Mice
  • Mice, Nude
  • Neoplasm Invasiveness (genetics, pathology)
  • Polyamines (metabolism)
  • Signal Transduction (drug effects)
  • Skin (pathology)
  • Skin Neoplasms (chemically induced, genetics, pathology)
  • Toll-Like Receptor 4 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: